The ASX 200 added 0.9% in the first hour on Friday, after both gold and silver futures gained more than ... Read More The ...
Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. (NASDAQ: INVA), today announced the publication of positive results from a pivotal Phase 3 trial evaluating its investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback